Search Results - "M Bryszewska"

Refine Results
  1. 1

    Dendrimers in photodynamic therapy by Klajnert, B, Rozanek, M, Bryszewska, M

    Published in Current medicinal chemistry (01-10-2012)
    “…Photodynamic therapy (PDT) is a promising approach to treat certain types of cancer. PDT was proposed as a useful oncology tool more than 30 years ago but it…”
    Get more information
    Journal Article
  2. 2

    Influence of dendrimer’s structure on its activity against amyloid fibril formation by Klajnert, B., Cortijo-Arellano, M., Cladera, J., Bryszewska, M.

    “…Inhibition of fibril assembly is a potential therapeutic strategy in neurodegenerative disorders such as prion and Alzheimer’s diseases. Highly branched,…”
    Get full text
    Journal Article
  3. 3

    Fluorescence studies on PAMAM dendrimers interactions with bovine serum albumin by Klajnert, B, Bryszewska, M

    “…Polyamidoamine (PAMAM) dendrimers (generation 3.5 and 4) interaction with bovine serum albumin (BSA) was studied. The intensity of intrinsic fluorescence of…”
    Get full text
    Journal Article
  4. 4

    Mechanism of neuroprotection of melatonin against beta-amyloid neurotoxicity by Ionov, M, Burchell, V, Klajnert, B, Bryszewska, M, Abramov, A.Y

    Published in Neuroscience (28-04-2011)
    “…Abstract The main component of senile plaques in Alzheimer's disease (AD), aggregated amyloid beta peptide (βA), is neurotoxic and implicated in AD pathology…”
    Get full text
    Journal Article
  5. 5

    Dendrimers: properties and applications by Klajnert, B, Bryszewska, M

    Published in Acta biochimica polonica (01-01-2001)
    “…Dendrimers are a new class of polymeric materials. They are highly branched, monodisperse macromolecules. The structure of these materials has a great impact…”
    Get full text
    Journal Article
  6. 6

    Dendrimers in gene transfection by Shcharbin, D. G, Klajnert, B, Bryszewska, M

    Published in Biochemistry (Moscow) (01-10-2009)
    “…Dendrimers are a new class of nanocomposite materials. They are branching polymers whose structure is formed by monomeric subunit branches diverging to all…”
    Get full text
    Journal Article
  7. 7

    Molecular Interactions of Dendrimers with Amyloid Peptides:  pH Dependence by Klajnert, B, Cladera, J, Bryszewska, M

    Published in Biomacromolecules (01-07-2006)
    “…The formation of amyloid plaques is a key pathological event in neurodegenerative disorders, such as prion and Alzheimer's diseases. Dendrimers are considered…”
    Get full text
    Journal Article
  8. 8

    Glycodendrimers as new tools in the search for effective anti-HIV DC-based immunotherapies by Córdoba, E. Vacas, MB, Pion, M., PhD, Rasines, B., PhD, Filippini, D., PhD, Komber, H., PhD, Ionov, M., PhD, Bryszewska, M., PhD, Appelhans, D., PhD, Muñoz-Fernández, M.A., PhD, MD

    Published in Nanomedicine (01-10-2013)
    “…Abstract Dendritic cells (DC), which play a major role in development of cell-mediated immunity, represent opportunities to develop novel anti-HIV vaccines…”
    Get full text
    Journal Article
  9. 9

    Molecular properties of lysine dendrimers and their interactions with Aβ-peptides and neuronal cells by Neelov, I M, Janaszewska, A, Klajnert, B, Bryszewska, M, Makova, N Z, Hicks, D, Pearson, H A, Vlasov, G P, Ilyash, M Yu, Vasilev, D S, Dubrovskaya, N M, Tumanova, N L, Zhuravin, I A, Turner, A J, Nalivaeva, N N

    Published in Current medicinal chemistry (2013)
    “…Prevention of amyloidosis by chemical compounds is a potential therapeutic strategy in Alzheimer's, prion and other neurodegenerative diseases. Regularly…”
    Get more information
    Journal Article
  10. 10

    Cytotoxicity and genotoxicity of cationic phosphorus-containing dendrimers by Gomulak, P, Klajnert, B, Bryszewska, M, Majoral, J P, Caminade, A M, Blasiak, J

    Published in Current medicinal chemistry (01-12-2012)
    “…Cationic phosphorus-containing dendrimers (CPDs) are a class of highly-branched polymers with potential medical relevance. However, little is known about CPD…”
    Get more information
    Journal Article
  11. 11

    Biophysical characterization of glycodendrimers as nano-carriers for HIV peptides by Ionov, M, Ciepluch, K, Moreno, B R, Appelhans, D, Sánchez-Nieves, J, Gómez, R, de la Mata, F J, Muñoz-Fernández, M A, Bryszewska, M

    Published in Current medicinal chemistry (01-10-2013)
    “…This paper examines the formation and stability of nano-complexes that could provide a new therapeutic approach against HIV-1 infection. Poly(propylene imine)…”
    Get more information
    Journal Article
  12. 12

    Melatonin directly scavenges free radicals generated in red blood cells and a cell-free system: Chemiluminescence measurements and theoretical calculations by Zavodnik, I.B., Domanski, A.V., Lapshina, E.A., Bryszewska, M., Reiter, R.J.

    Published in Life sciences (1973) (20-06-2006)
    “…Melatonin, a pineal secretory product, has properties of both direct and indirect powerful antioxidant. The aim of the present study was to compare the…”
    Get full text
    Journal Article
  13. 13

    Influence of PAMAM dendrimers on human red blood cells by Domański, D.M., Klajnert, B., Bryszewska, M.

    “…Polyamidoamine (PAMAM) dendrimers with different concentrations (1 nM–1 mM) (generations 2, 3, and 4) impact on human red blood cell morphology, and membrane…”
    Get full text
    Journal Article
  14. 14

    Highly organized self-assembled dendriplexes based on poly(propylene imine) glycodendrimer and anti-HIV oligodeoxynucleotides by Maly, J, Pedziwiatr-Werbicka, E, Maly, M, Semeradtova, A, Appelhans, D, Danani, A, Zaborski, M, Klajnert, B, Bryszewska, M

    Published in Current medicinal chemistry (01-09-2012)
    “…Dendrimers are artificial polymeric macromolecules which are widely considered to be a promising tool for future gene therapy applications. They have been used…”
    Get more information
    Journal Article
  15. 15

    Non-viral engineering of skin precursor-derived Schwann cells for enhanced NT-3 production in adherent and microcarrier culture by Shakhbazau, A, Shcharbin, D, Bryszewska, M, Kumar, R, Wobma, H M, Kallos, M S, Goncharova, N, Seviaryn, I, Kosmacheva, S, Potapnev, M, Midha, R

    Published in Current medicinal chemistry (01-11-2012)
    “…Genetic engineering of stem cells and their derivatives has the potential to enhance their regenerative capabilities. Here, dendrimer- and lipofection-based…”
    Get more information
    Journal Article
  16. 16

    DSC studies on interactions between low molecular mass peptide dendrimers and model lipid membranes by Klajnert, B., Janiszewska, J., Urbanczyk-Lipkowska, Z., Bryszewska, M., Epand, R.M.

    Published in International journal of pharmaceutics (11-12-2006)
    “…It has recently been shown that a newly synthesized peptide dendrimers possess antimicrobial activity against Gram-positive ( Staphylococcus aureus) and…”
    Get full text
    Journal Article
  17. 17

    Studying Complexes Between PPI Dendrimers and Mant-ATP by Szulc, A., Appelhans, D., Voit, B., Bryszewska, M., Klajnert, B.

    Published in Journal of fluorescence (01-03-2013)
    “…The aim of this study was to investigate the interactions between poly(propylene imine) (PPI) dendrimers and 2′-/3′-O-(N′-methylanthraniloyl)-ATP (Mant-ATP)…”
    Get full text
    Journal Article
  18. 18

    The effect of PAMAM dendrimers on human and bovine serum albumin at different pH and NaCl concentrations by Shcharbin, D., Klajnert, B., Bryszewska, M.

    “…The effect of PAMAM G3.5, PAMAM G4 and PAMAM-OH G4 dendrimers on human and bovine serum albumins has been studied by fluorescence spectroscopy at different pH…”
    Get full text
    Journal Article
  19. 19

    Fourth generation phosphorus-containing dendrimers: prospective drug and gene delivery carrier by Shcharbin, D, Dzmitruk, V, Shakhbazau, A, Goncharova, N, Seviaryn, I, Kosmacheva, S, Potapnev, M, Pedziwiatr-Werbicka, E, Bryszewska, M, Talabaev, M, Chernov, A, Kulchitsky, V, Caminade, A-M, Majoral, J-P

    Published in Pharmaceutics (05-08-2011)
    “…Research concerning new targeting delivery systems for pharmacologically active molecules and genetic material is of great importance. The aim of the present…”
    Get full text
    Journal Article
  20. 20

    Biological properties of low molecular mass peptide dendrimers by Klajnert, B., Janiszewska, J., Urbanczyk-Lipkowska, Z., Bryszewska, M., Shcharbin, D., Labieniec, M.

    Published in International journal of pharmaceutics (17-02-2006)
    “…A series of new, low molecular mass, lysine-based peptide dendrimers with varying distribution of cationic and aromatic groups in the structure were…”
    Get full text
    Journal Article